Deutsche Bank
ARRY

Deutsche Bank’s Array Biopharma Inc ARRY Stock Holding History

Deutsche Bank’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-405
Closed -$1K – 6210
2014
Q2 		$1K Buy
+405
New +$1.68K ﹤0.01% 5817
2014
Q1 		– Sell
-800
Closed -$1K – 5881
2013
Q4 		$1K Hold
800
– – ﹤0.01% 5331
2013
Q3 		$1K Buy
+800
New +$4.75K ﹤0.01% 5472

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Deutsche Bank's ARRY Position: Q3 2019 in Review

Deutsche Bank sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 1,305,214 shares — an estimated $60.5M sold.

Deutsche Bank first reported a position in ARRY in Q2 2013 and held it in 25 quarters. The position peaked at $60.5M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Deutsche Bank reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Deutsche Bank sold 1,305,214 Array Biopharma Inc shares in Q3 2019, an estimated $60.5M.
  • Deutsche Bank first reported a position in Array Biopharma Inc in Q2 2013 and held it in 25 quarters.
  • Deutsche Bank's Array Biopharma Inc position peaked at $60.5M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Deutsche Bank's 13F filing for Q3 2019, filed 14 Nov 2019.